DEWB AG Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG: NOXXON Pharma announces experienced industry cancer clinician Dr. Jarl Ulf Jungnelius to serve as NOXXON CMO
Focus on oncology allows recruitment of specialist involved in approval of multiple oncology agents
